Interestingly, the detection of DLGAP5 mRNA in urine was a valuable noninvasive test for early diagnosis of bladder cancer and bloodstream bladder cancer, which improved the sensitivity of urine cytology by up to 91% [35]. The gene discussed is DLGAP5; the disease is urinary bladder carcinoma.